Glycom is a Danish biotechnology brand dedicated to improving human health with their products and services. Their primary focus is on the scientific, clinical, and commercial development of Human Milk Oligosaccharides (HMOs) for a wide range of health applications. As the world's leading HMO supplier, Glycom stands out as the sole fully integrated player in the field, with expertise in product development, preclinical and clinical development, regulatory compliance, and large-scale production.

Their competent and multicultural team, consisting of over 150 dedicated employees from more than 18 countries, brings a diverse range of professional disciplines to the table. Glycom is committed to doing the Right Things Right, taking responsibility, and keeping commitments by ensuring attention to detail and working with the right people. Headquartered in Hørsholm, Denmark, Glycom's ISO-certified facilities in Esbjerg, Denmark, support their dedication to HMO production.

Their HMOs are widely used as a key ingredient in infant nutrition, as well as in supplements and foods for children and adults worldwide. Glycom also plays a vital role in promoting ongoing HMO research through their HMO Donation Program, aimed at advancing understanding of the health benefits and potential applications of HMOs. With world-class R&D capabilities and a commitment to improving human health, Glycom is dedicated to creating a positive impact on the well-being of individuals and communities